Skip to main content
ATOS logo

ATOS

Atossa Therapeutics, Inc.
$2.12 +0.08 (+3.92%) At close · Jul 2
Market Cap
$18.26M
Shares
8,611,361

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 34
Total Value: $6,811,570
Total Shares: 1,294,979

Institutional Ownership Trend

3 quarters

Holder Concentration

Across 34 13F filers · Δ vs Dec 31, 2025
Top Holder
27.0%
Jun 2025 → Mar 2026 · range 27.0% – 100.0%
−73.0 pts
Top 5
72.9%
Jun 2025 → Mar 2026 · range 72.9% – 100.0%
−27.1 pts
Top 10
96.5%
Jun 2025 → Mar 2026 · range 96.5% – 100.0%
−3.5 pts
HHI
1,472
Jun 2025 → Mar 2026 · range 1,472 – 10,000
Broadly held−8,528

Quarterly Activity

vs Dec 31, 2025
New
34
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count: +33
Institutional value: +2641.8%
Shares held: +4513.1%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 34 of 34
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1488039 CUSIP 04962H704 13F (30d) 1 filings 1 filers Visit website Investor relations